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Edited by Lukas HuberAbstract In this study, the eﬀect of oleic acid (50 lM) on gene
expression of Jurkat cells (human T lymphocytes cell line) was
examined using the suppressive subtractive hybridization ap-
proach. This technique allowed us to identify genes with higher
or lower expression after cell treatment with oleic acid as
compared to untreated cells. Oleic acid upregulated the expres-
sion of the translation elongation factor alpha 1 and ATP
synthase 8 and downregulated gp96 (human tumor rejection
antigen gp96), heat-shock protein 60 and subtilisin-like protein 4.
These results suggest that oleic acid, at plasma physiological
concentration, can regulate the expression of important genes to
maintain the machinery that ensures cell functioning.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Both the amount and the type of dietary fat play a role in the
health of individuals. Consumption of lipids with a high pro-
portion of saturated fatty acids (SFA) has been associated with
increased risk of developing coronary heart disease, as shown
by the Seven Country Study [1]. Subsequent studies showed
that replacement of SFA with either mono- or polyunsaturated
fatty acids (PUFA or MUFA) might be beneﬁcial [2,3]. The
Mediterranean diet has been widely recognized as a model for
a healthy diet, since these countries display the lowest rate of
chronic heart diseases [4]. This diet is characterized by a high
consumption of olive oil, which is rich in oleic acid, a MUFA.
There has been great interest in the eﬀects of oleic acid on li-
poprotein metabolism and atherosclerosis [3]. Although cells
of the immune system are an inherent part of the inﬂammatory
events involved in the development and progression of ath-* Corresponding author. Fax: +55-11-3091-7245.
E-mail address: ruicuri@ﬁsio.icb.usp.br (R. Curi).
Abbreviations: EF-1a, translation elongation factor 1 alpha; EFA,
essential fatty acids; FA, fatty acid; MUFA, monounsaturated fatty
acid; NK, natural killer; PCR, polymerase chain reaction; PUFA,
polyunsaturated fatty acid; SFA, saturated fatty acids; SPC4, subtil-
isin-like protein 4
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doi:10.1016/j.febslet.2004.09.025erosclerosis, less attention has been paid to the eﬀects of these
fatty acids (FA) on leukocytes.
Olive oil has classically been used as placebo in studies in-
vestigating the eﬀects of ﬁsh oils on immune function, since
MUFA has typically been regarded as being neutral [5,6].
However, some clinical trials have reported the eﬀects of olive
oil treatment that are equal or similar to the eﬀects of ﬁsh oil
treatment [7–9]. Rats fed with a diet rich in oleic acid present
low rate of proliferation of mesenteric lymph node lympho-
cytes [10,11], suppressed NK cell activity [12] and low ex-
pression of the adhesion molecules CD2, ICAM-1 and LFA-1
[13]. Similar results were obtained in human studies [14,15].
Several mechanisms have been proposed to explain FA
modulation of the immune response. Although some of the
eﬀects may be brought about by modulation of the amount
and type of eicosanoids produced, FA also elicit some of their
eﬀects by arachidonic acid-independent mechanisms, including
actions upon intracellular signaling pathways and transcrip-
tion factor activity [16,17]. In addition, FA are also known to
regulate gene expression [18–20]. Therefore, the beneﬁcial ef-
fects of the Mediterranean diet may be related to changes in
gene expression induced by oleic acid.
In order to investigate oleic acid-regulated genes, Jurkat cells
(a human T-lymphocyte cell line) were treated with this FA in
a concentration within the plasma physiological range (50
lM), for a suﬃcient exposure time (24 h) and subjected to the
suppressive subtractive hybridization (SSH) technique to iso-
late genes whose expression was regulated by oleic acid treat-
ment. In SSH, diﬀerentially expressed sequences are enriched
and the concentration of high- and low-abundance sequences
is equalized. SSH is a highly eﬃcient and widely used poly-
merase chain reaction (PCR)-based method for identifying
diﬀerentially expressed genes [21–24].2. Material and methods
2.1. Chemicals
Cell culture medium, antibiotics, fetal calf serum and TRIzol reagent
were obtained from Invitrogen (Grand Island, NY, USA). All other
reagents were obtained from Sigma (St. Louis, MO).
2.2. Cell culture conditions
Jurkat (human T-lymphocytes) cells were obtained from the Dunn
School of Pathology (Oxford University, UK). Cells maintained in log-
phase growth at 37 C and 5% CO2 humidiﬁed atmosphere were grownblished by Elsevier B.V. All rights reserved.
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mM HEPES, 10 U/ml ampicillin and 10 lg/ml streptomycin. The cell
population was maintained at densities between 1 105 and 1 106
cells/ml.
2.3. Cell treatment
Cells were diluted to 2 105 cells/ml in 75 cm3 bottles. On the fol-
lowing day, when the number of cells reached 4 105 cells/ml, oleic
acid, diluted in ethanol, was added to the ﬁnal concentration of 50 lM.
Previous study has shown that higher concentrations of oleic acid are
toxic to Jurkat cells [25]. Control cells were treated with the same
amount of ethanol, which was always lower than 0.05%. This con-
centration of ethanol has shown to be non-toxic for the cells. The cells
were cultured with the FA at 37 C and 5% CO2 humidiﬁed atmo-
sphere for 24 h.
2.4. RNA extraction
Total RNA from control (untreated) and oleic acid-treated cells was
extracted using TRIzol reagent. Poly(A)þ RNA was isolated using the
QuickPrepTM mRNA Puriﬁcation Kit* (Amersham Biociences, Frei-
burg, Germany).
2.5. Suppression subtractive hybridization (SSH) and cDNA library
construction
cDNA synthesis and SSH were carried out using the PCR-
SelectTM cDNA Subtraction Kit (CLONTECH Laboratories, Cali-
fornia, USA) with the modiﬁed protocol of Rebrikov et al. [26]. Two
micrograms of poly(A)þ RNA from control and oleic acid-treated
cells was used for cDNA synthesis. For the forward subtraction,
cDNA from control cells was used as the driver and cDNA from
treated cells was used as the tester. The opposite was used for the
reverse subtraction. The forward subtraction was performed to iso-
late genes whose expression increased after the treatment. The re-
verse library contains genes whose expression is decreased upon
treatment. After digestion with RsaI, tester cDNA preparations were
divided into two subpopulations, which were annealed to diﬀerent
adaptors. The two sub-populations were then hybridized with an
excess amount of driver cDNA, after which they were combined and
hybridized again in the presence of driver cDNA, without denaturing
the DNA before the second hybridization. Following the second
hybridization, two PCR rounds were performed to enrich and am-
plify the diﬀerentially expressed sequences.
The PCR products obtained from the forward and the reverse sub-
tractions were cloned into the pUC18 plasmid (Amersham Biociences,
Freiburg, Germany). Randomly selected clones were arrayed in 96 well
microtiter dishes with 200 ll Luria–Bertrani broth containing ampi-
cillin (100 lM/ml) and grown overnight on a shaker.
2.6. Reverse Northern blotting
One microliter of the bacterial cultures was used as the template in
PCRs and the products were spotted onto nylon membranes using
the ExprecisionTM DNA Arraying System (Bioinformatica, Camp-
inas, Brazil). Reverse Northern blotting was performed with
[32P]dATP-labeled subtracted cDNA from both forward and reverse
subtractions.
The arrayed membranes were pre-hybridized at 42 C for 3 h in
hybridization solution (50% formamide, 6SSC, 5Denhardt’s so-
lution, 1% SDS, 0.5 lg/ml poly-dA and 0.5lg/ml Cot1-DNA), after
which the denatured probe was added to the solution and hybridized to
the membranes at 42 C overnight. Following hybridization, the
membranes were washed twice in 2SSC/1% SDS at room tempera-
ture for 15 min, twice in 0.1 SSC/0.5% SDS at 65 C for 20 min, and
once in 0.1SSC/0.5% SDS at 68 C for 15 min. After the ﬁnal wash,
the membranes were exposed to Phosphoimager screens (Molecular
Dynamics Inc., Sunnyvale, CA) for 5–7 days.
2.7. Data analysis
Hybridization signals were detected and analyzed using a Phos-
phoimager scanner and the ImageQuanNT software program (Mo-
lecular Dynamics).
2.8. Northern blot hybridization
cDNAs displaying diﬀerential expression between control and oleic
acid-treated cells were identiﬁed and the results were conﬁrmed by
Northern blotting. Twenty micrograms of total RNA from controland oleic acid-treated cells were fractionated by electrophoresis
through agarose-formaldehyde gels and blotted onto nylon mem-
branes as previously described [27]. The PCR products derived from
the selected clones and from the b-actin gene were labeled with [a-
32P]dATP and used as probes to hybridize with the nylon mem-
branes. Hybridization and data analysis were carried out as
described before.
2.9. DNA sequencing
Sequencing of the cDNA clones was performed with the M13 pri-
mer, using an ABI PRISM BigDyeTM Terminator Cycle Sequencing
Ready Reaction Kit (Perkin–Elmer Corp., Foster City, CA) and an
ABI 310 sequencer (Perkin–Elmer).3. Results
3.1. Screening of the recombinant plasmids obtained after
forward and reverse cDNA subtractions
The PCR products obtained from the forward and the
reverse subtractions were cloned into pUC18 plasmids. We
obtained 14 microtiter (96 well) dishes of clones from the
forward subtraction and 16 microtiter dishes of clones from
the reverse subtraction, corresponding to 1344 genes whose
expression increased and 1536 genes whose expression de-
creased after oleic acid treatment. Due to the possible pres-
ence of the so-called ‘‘false positive’’ clones, recombinant
plasmids were ﬁrst submitted to a primary screening by re-
verse Northern blotting.
All PCR products were immobilized in nylon membranes
using the ExprecisionTM DNA Arraying System (Bioin-
formatica, Campinas, Brazil). We constructed two distinct
membranes with the forward subtraction clones and two other
membranes with the reverse subtraction clones. All clones were
spotted in duplicate. An exact copy of each membrane was
generated to allow simultaneous hybridization with
[32P]dATP-labeled subtracted cDNA probes from both the
forward and the reverse subtractions (Fig. 1).
The signal intensities of all PCR products were analyzed and
only those with a 5-fold diﬀerence between forward and re-
verse probe hybridization were considered as candidates to be
regulated by oleic acid treatment. Similar protocols were used
by others [27,28]. Only 36 clones (2.7%) from the forward
subtraction and 25 (1.6%) from the reverse subtraction pre-
sented the 5-fold signal diﬀerence. Most clones obtained were
‘‘false positives’’.
3.2. Northern blot analysis
All clones selected by the reverse Northern blotting meth-
odology were PCR-ampliﬁed and the products were labeled
with [32P]dATP. These probes were used to hybridize to nylon
membranes that contained 20 lg of total RNA from Jurkat
cells treated with ethanol (control) or with oleic acid. The b-
actin gene was also ampliﬁed and used as a control house-
keeping gene.
The signal intensities were normalized in comparison with
the b-actin gene signal and only clones B4/R15, E10/F9, F5/
R10, G9/F14 and H11/R13 had their expression signiﬁcantly
altered (over 50%) after the treatment with oleic acid. These
results are presented in Fig. 2.
The sequences of these clones were determined using auto-
mated cycle sequencing and compared with previously identi-
ﬁed genes deposited in the GenBank. Table 1 shows the results
obtained.
Fig. 1. Reverse Northern blotting analysis of clones obtained after forward and reverse cDNA subtractions from Jurkat cells treated with ethanol
(vehicle) or oleic acid. Each membrane contained clones plotted in duplicate. They were hybridized with [32P]dATP-labeled cDNA from both
forward and reverse subtractions (forward and reverse probes).
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FA are very important for normal physiological functioning.
Saturated FA are involved in energy production, energy stor-
age, synthesis of phospholipids and sphingolipids required for
membrane synthesis, and covalent modiﬁcation of several
regulatory proteins. MUFA are also involved in many of these
processes and play a key role in maintaining optimal ﬂuidity of
the membrane lipid bilayer [29]. Although these are vital
physiological processes, the term ‘‘essential’’ is not applied to
saturated or MUFA. The designation is reserved for those
PUFA that are required for good health but cannot be com-
pletely synthesized in the body.
Recent reviews have proposed a new terminology for the so-
called ‘‘essential’’ FA (EFA), based on their conditional re-quirement during speciﬁc situations throughout individuals’
life time (such as childhood, pregnancy, lactation and cancer)
[29–31]. Essentiality connotes a more important role for these
FA than for those that can be endogenously produced. For
example, FA known as essential, such as linoleate, a-linolenate
and docosahexaenoate contribute signiﬁcant amounts of car-
bon to the synthesis of non-essential fatty acids [32,33].
Moreover, under certain circumstances, EFA can be prefer-
entially oxidized relative to non-EFA [34,35]. Thus, there are
circumstances in which EFA seem less important (less con-
served) than non-EFA. There is also evidence that oleate
cannot be synthesized in suﬃcient amounts to maintain tissue
levels that are routinely observed when it is present in the diet
[36]. Reduced tissue levels of a FA, by itself, constitute an
insuﬃcient justiﬁcation for a dietary requirement but this is a
Table 1
Genes with altered expression upon treatment of Jurkat cells with oleic acid (50 lM)
Clone Identity Expression variation (%) GenBank Accession No.
B4/R15 Human tumor rejection antigen gp96 )80 CO960795
F5/R10 Heat shock protein 60 kDa )57 CO960796
H11/R13 Subtilisin-like protein 4 (SPC 4) )90 CO960797
D10/F9 Translation elongation factor 1 alpha 1 +100 CO960798
G9/F14 ATP synthase subunit 8 +115 CO960799
Fig. 2. Northern blotting analysis of clones identiﬁed by reverse northern blotting. Total RNA from Jurkat cells treated with ethanol (open bars) or
oleic acid (hatched bars) was immobilized in nylon membranes and hybridized with [32P]dATP-labeled PCR products of the chosen clones. Equal
loading of samples was conﬁrmed by hybridization with a [32P]dATP-labeled b-actin probe. Hybridization signals were detected and analyzed using a
Phosphoimager scanner and ImageQuanNT software program (Molecular Dynamics). The results of gene expression were calculated in relative
values (relative expression) between OD of interest gene and that of b-actin.
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should then be replaced by conditional requirement, a concept
that comprises the balance between production and con-
sumption of a speciﬁc FA in a particular situation.
Our study presents evidence that oleic acid, a so-called non-
EFA, has an important role in maintenance of T-lymphocyte
homeostasis. We show that the treatment of Jurkat cells with
50 lM of oleic acid increases the expression of translation
elongation factor 1 alpha 1 (EF-1a, 100%) and of ATP syn-
thase subunit 8 (115%). The expression of human tumor
rejection antigen gp96, heat-shock protein 60 kDa and sub-
tilisin-like protein (SPC4) was suppressed by oleic acid treat-
ment, by 80%, 57% and 90%, respectively.
The ATP synthases comprise a large family of enzymes,
which members are found in the bacterial cytoplasmic mem-
brane, the inner membrane of mitochondria and the thylakoid
membrane of chloroplasts. This enzyme is responsible for the
production of ATP, the universal carrier of cell energy, from
ADP and phosphate, using free energy from an electrochem-
ical gradient of protons. The energy provided by ATP hy-
drolysis is necessary for active transport of ions and molecules
and macromolecules synthesis [37]. Increased expression of
ATP synthase, as induced by oleic acid treatment, ensures
adequate energy supply for the cells’ regular functions.The EF-1a is a nucleotide exchange protein that binds GTP
and aminoacyl-tRNAs. It is responsible for their codon-de-
pendent placement at the A-site of the ribosome [38,39] and
guarantees translation ﬁdelity. EF-1a is physically associated
and may be an important element in mitotic spindle formation
[40], possibly playing a role in growth control, cell division and
survival. Overexpression of EF-1a has been associated with
extended lifespan in ﬂies [41] and suppression of non-sense
mutations in yeast [42]. Thus, its increased expression upon
oleic acid treatment may have a protective eﬀect on T-lym-
phocytes.
Proteolytic processing is a post-translational modiﬁcation by
which the cell can diversify and regulate the levels of gene
products. In fact, processing is important in zymogen activa-
tion, mature peptide hormone generation, complement acti-
vation, clot formation and lysis, angiogenesis and tissue
remodeling. In mammalian species, this catalytic function is
carried out by a family of subtilisin-related pro-protein con-
vertases, among which is SPC4 [43]. They appear to be highly
speciﬁc enzymes, cleaving pro-protein precursors at speciﬁc
positively charged amino acids, usually to produce biologically
active products. Among the reported SPC4 substrates are pro-
neurotrophin 3 [44], the insulin receptor [45], pro-nerve growth
factor [46], pro-somatostatin [47] and human serum albumin
324 T. Martins de Lima et al. / FEBS Letters 576 (2004) 320–324[48]. But the role of SPC4 in vivo remains unclear, as none of
the precursors cited above demonstrates a clear preferential
susceptibility to SPC4 activity.
Human tumor rejection antigen gp96 and heat-shock protein
60 kDa are members of the protein family known as chaper-
ones. These proteins play a crucial role in cell recovery from
stress and in cytoprotection, guarding cells from subsequent
insults. An increase in the expression of these proteins is ob-
served upon stress conditions [49,50]. They protect stressed cells
by recognizing nascent polypeptides, unstructured regions of
proteins and exposed hydrophobic stretches of amino acids. In
doing so, chaperones hold, translocate or refold stress-dena-
turated proteins and prevent their irreversible aggregation with
other proteins in the cell [50,51]. The reduced expression of
these proteins upon oleic acid treatment may indicate that the
cells do not consider oleic acid supplementation as a stress
condition. This issue deserves to be further investigated.
The results presented herein led us to postulate that oleic
acid, at plasma physiological concentration, may regulate the
expression of important genes to maintain the machinery that
ensures cell functioning. In addition, our results corroborate
with the discussion on the importance of the so-called non-
essential FA to ensure the normal cell functioning.
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